Centre Hospitalier Le Vinatier

The medical center is at the forefront of exploring the intersection between psychiatric disorders and auto-immunity. Through innovative research, the center is evaluating the efficacy of immunotherapy as an adjunct to traditional psychiatric care, aiming to enhance treatment outcomes for patients with psychotic symptoms linked to immune dysfunction.

• Psychotic symptoms and auto-immunity
• Integration of immunotherapy in psychiatric care

This research is pioneering new pathways in understanding and treating mental health conditions with an immune component, potentially transforming therapeutic approaches.

Focusing on Autism Spectrum Disorders (ASD), the center is conducting groundbreaking studies to assess the impact of novel treatments on social communication and interaction deficits. By evaluating the effects of medications like pitolisant and pimavanserin, the center aims to improve the quality of life for young individuals with ASD.

• Social communication and interaction in ASD
• Long-term safety and tolerability of treatments

These studies are crucial in developing effective, long-term therapeutic strategies for managing ASD symptoms, particularly in pediatric populations.

The center is advancing the field of addiction medicine by investigating the efficacy of treatments like Sodium Oxybate and Cannabidiol (CBD) in reducing alcohol consumption and promoting abstinence. These studies focus on individuals with high-risk drinking behaviors, aiming to provide new solutions for managing alcohol addiction.

• Reduction of alcohol consumption
• Maintenance of abstinence in alcohol-dependent individuals

By exploring these innovative treatments, the center is contributing to the development of more effective interventions for alcohol use disorders, addressing both the physiological and psychological aspects of addiction.